DLBCL patients with a history of extensive prior chemotherapy have fewer naïve and minimally differentiated T-cells, including increased populations of CD27 and CD28 double- negative senescent cells, when compared to healthy controls and newly diagnosed DLBCL patients (69). The gene discussed is CD27; the disease is diffuse large B-cell lymphoma.